Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in

E Matuszczak1, M Tylicka2, W Dębek1

  • 1Department of Pediatric Surgery, Medical University of Bialystok, Poland.

Insights

Circulating proteasome activity increases after burn injury in children. This activity correlates with burn severity and may serve as a biomarker for tissue damage.

Area of Science:

  • Biochemistry
  • Pediatric Surgery
  • Biomarkers

Background:

  • Burn injuries in children can lead to significant systemic complications.
  • Assessing tissue damage and inflammatory responses is crucial for effective management.
  • Circulating proteasome activity is a potential indicator of cellular stress and damage.

Purpose of the Study:

  • To analyze circulating proteasome (c-proteasome) activity in pediatric burn patients.
  • To correlate c-proteasome activity with plasma total protein and C-reactive protein (CRP) levels.
  • To investigate the relationship between c-proteasome activity and burn severity.

Main Methods:

  • Fifty pediatric patients with scald burns (4-20% TBSA) were studied.
  • Plasma proteasome activity was measured at various time points post-injury.
  • Activity was assessed using a specific peptide substrate; healthy children served as controls.

Main Results:

  • Elevated plasma c-proteasome activity was observed 12-16 hours post-burn in all patient groups.
  • C-proteasome activity showed a negative correlation with total protein and a positive correlation with CRP levels.
  • C-proteasome activity correlated more strongly with burn severity than CRP levels at 12-16 hours and 3 days post-burn.

Conclusions:

  • Circulating 20S proteasome activity increases following burn injury in children.
  • Plasma 20S proteasome activity negatively correlates with total protein levels.
  • Plasma 20S proteasome activity shows potential as an additional biomarker for tissue damage in pediatric burn patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
698